TickerSparkInvestor Intelligence
TickerSparkInvestor Intelligence
How It Works
Start Here
Spark Generator
Stock Deep Dives
AI Analyst
Agentic Chat
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio
My Portfolio
Brokerage Connected
Spark Charts
AI Technical Analysis
Main Feed
Today's Market Intel
Stock Reports
AI Research Reports
Top Stocks
AI-Curated Stock Lists
Commentary
Opinionated Stock Takes
Trending Stocks
Today's Big Movers
Earnings Coverage
Flashes & Deep Dives
Macro Updates
Economy & Markets
IPO Calendar
Upcoming Listings
Members AreaMembers Area
Log inCreate Account
← Back to TickerSpark
▌Earnings Flash·May 6, 2026

Cencora, Inc. (COR) slumps on earnings misses

Cencora, Inc. (COR) slumps 17.4% after reporting earnings misses, as investors react to weaker-than-expected results and pressure on the stock.

Earnings FlashCORHealthcareMedical - Distribution
By TickerSpark·May 6, 2026·2 min read
Cencora, Inc. (COR) slumps on earnings misses
▌Key Takeaway
Cencora, Inc. (NYSE: COR) reported a double miss, with EPS of $4.75 versus $4.82 expected and revenue of $78.36 billion versus $81.09 billion expected. The stock fell 17.40% to $252.66 as investors sharply repriced the shares after a run of prior earnings beats, signaling weaker near-term confidence in execution.

Cencora, Inc. (COR) missed on both profit and revenue, posting EPS of $4.75 versus $4.82 expected and revenue of $78.36B versus $81.09B expected, and the stock slumped 17.40% in regular-session trading to $252.66.

Key Numbers

  • EPS: $4.75 actual vs $4.82 estimated, a miss.
  • Revenue: $78.36B actual vs $81.09B estimated, a miss.
  • Stock reaction: COR fell 17.40% in regular-session trading to $252.66 from the prior close of $305.90.

§ Product

  • How It Works
  • Spark Generator
  • AI Analyst
  • Plans

§ Research

  • Main Feed
  • Stock Reports
  • Macro Updates
  • Blog

§ Company

  • About Us
  • Contact

§ Fine Print

  • Terms of Service
  • Privacy Policy
  • Full Disclaimer
  • Cookie Policy

Notice: All content and data on TickerSpark is for informational purposes only and does not constitute financial or investment advice. All investments involve risk. Please see our Full Disclaimer for more details.

© 2026 Maxwell Cyberlogic LLC

Not Investment Advice

Made in Delaware, USA

  • Trading range: shares moved between $244.82 and $268.02 during the session.
  • Volume: 2,337,503 shares traded versus an average of 1,357,673.

    • A sharp break after a strong streak

    This quarter broke Cencora's recent pattern. COR had topped EPS estimates in each of the prior four quarters, including $4.08 versus $4.05 in February and $3.84 versus $3.79 in November. This time, both the profit line and the top line came in short, and the market treated that as a real reset, not a minor wobble.

    The size of the stock move matters. A 17.40% drop in regular-session trading, with volume well above average, shows investors repriced the shares fast. For a healthcare distributor, that kind of reaction usually means the miss hit confidence in execution. In plain English, the market had grown used to Cencora clearing the bar. This quarter it did not.

    The near-term read is simple: Cencora is still a very large business at $78.36B in quarterly revenue, but scale did not protect it from a miss. After a run of earnings beats, that shift changes the tone around COR.

    Bottom Line

    Cencora's double miss snapped a solid earnings streak, and the 17.40% selloff shows investors are no longer giving COR the benefit of the doubt.

    Read the full COR research report
    ▌Common Questions

    Frequently asked questions

    +Why did Cencora stock fall so much after earnings?
    Cencora, Inc. (COR) fell because it missed both earnings and revenue expectations, posting EPS of $4.75 versus $4.82 expected and revenue of $78.36 billion versus $81.09 billion expected. The stock dropped 17.40% in regular-session trading to $252.66 as investors reacted to the double miss.
    +Did Cencora beat or miss earnings this quarter?
    Cencora, Inc. (COR) missed on both the bottom line and the top line this quarter. It reported EPS of $4.75 and revenue of $78.36 billion, both below estimates of $4.82 and $81.09 billion, respectively.
    +How much did COR stock move after the earnings report?
    COR stock fell 17.40% in regular-session trading to $252.66 from the prior close of $305.90. The shares traded between $244.82 and $268.02 during the session on volume of 2,337,503 shares, above the average of 1,357,673.
    +What does Cencora's earnings miss mean for investors?
    The miss suggests investors are no longer giving Cencora the benefit of the doubt after a streak of prior earnings beats. The sharp selloff indicates the market is resetting expectations for execution and near-term performance.
    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌The Full Report

    Want the full picture on COR?

    The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.

    Read the COR report →Get Full Access →

    Not ready to subscribe? ·

    ▌The Full Report

    Get the full COR research report

    • Analyst-grade deep dive
    • Charts, valuation, grades
    • Buy/sell price targets
    Read the COR report →
    ▌For Active Investors

    Smarter research, on every ticker

    • Daily market intelligence
    • On-demand stock analysis
    • AI analyst chat
    Get Full Access →

    Cancel anytime

    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, free in your inbox.

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌More on COR

    More to read

    All articles
    Cencora, Inc. (COR) slumps on Q2 miss: deep earnings analysis
    COR

    Cencora, Inc. (COR) slumps on Q2 miss: deep earnings analysis

    Cencora, Inc. (COR) slumps after missing on EPS and revenue, but the full story goes beyond the headline. This deep-dive unpacks U.S. Healthcare Solutions pressure, international strength, margin shifts, and why raised EPS guidance couldn’t offset a revenue reset.

    May 7·11 min
    Cencora, Inc. (COR) slumps 17% after mixed Q2
    COR

    Cencora, Inc. (COR) slumps 17% after mixed Q2

    Cencora, Inc. (COR) slumps after a mixed fiscal Q2 2026 report. Revenue rose and full-year guidance increased, but adjusted EPS missed expectations, sparking heavy selling as investors reassess the stock’s premium valuation and execution outlook.

    May 6·6 min
    Cencora (COR): Specialty Growth Is Driving Earnings
    COR

    Cencora (COR): Specialty Growth Is Driving Earnings

    Cencora is using specialty expansion and GLP-1 volume to grow earnings faster than revenue. The stock looks constructive for medium-term investors, with solid guidance and a reasonable forward valuation.

    May 6·22 min